Conference Call and Webcast November 14 at 8:00 AM Eastern Time / 7:00 AM Central Time
Updated Amendment to Phase 2/3 ReMEDy2 AIS Protocol Aimed at Enhancing Patient Enrollment and Increasing.
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NDRF imparts training to APSDRF personnel on rescue techniques during calamities thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Conference Call and Webcast August 15 at 8:00 am Eastern Time / 7:00 am Central Time
Company Resumes ReMEDy2 Clinical Trial after Clinical Hold Lifted
Company Completed a $37.5M. -Today at 04:14 pm- MarketScreener
Conference Call and Webcast May 16 at 8:00 am Eastern Time / 7:00 am Central Time
Company Completed In-Use Study, Results Support Proposed ReMEDy2 IV Dose Revision
Company Completed a Phase 1C. | May 15, 2023